1. The relation between cancer patient treatment decision-making roles and quality of life
- Author
-
Brent Diekmann, Tenbroeck Smith, Mashele Huschka, Pamela J. Atherton, Jeff A. Sloan, Jasvinder A. Singh, and Jef Huntington
- Subjects
Gerontology ,Response rate (survey) ,Cancer Research ,business.industry ,media_common.quotation_subject ,Concordance ,Cancer ,Anger ,Standard score ,Profile of mood states ,medicine.disease ,humanities ,Mood ,Oncology ,Quality of life ,Medicine ,business ,media_common ,Clinical psychology - Abstract
BACKGROUND The objective of this study was to explore relations between patient role preferences during the cancer treatment decision-making process and quality of life (QOL). METHODS One-year cancer survivors completed a survey in 2000 as part of a larger survey conducted by the American Cancer Society. The current report was based on survey respondents from Minnesota (response rate, 37.4%). Standardized measures included the Profile of Mood States (scores were converted to have a range, from 0 to 100, with 100 indicating the best mood), the Medical Outcomes Survey 36-item short-form health survey (SF-36) (standardized scores), and the Control Preferences Scale. Patients' actual and preferred role preference distributions and concordance between roles were compared with QOL scores using 2-sample t test methodology. RESULTS The actual role of survivors (n = 594) in cancer care was 33% active, 50% collaborative, and 17% passive. Their preferred role was 35% active, 53% collaborative, and 13% passive. Overall, 88% of survivors had concordant preferred and actual roles. Survivors who had concordant roles had higher SF-36 Physical Component Scale (PCS) scores (P
- Published
- 2013